CN117987446A - Genetic mutation engineering bacteria for producing phenazine-1-carboxylic acid, construction method and application thereof - Google Patents
Genetic mutation engineering bacteria for producing phenazine-1-carboxylic acid, construction method and application thereof Download PDFInfo
- Publication number
- CN117987446A CN117987446A CN202410214630.2A CN202410214630A CN117987446A CN 117987446 A CN117987446 A CN 117987446A CN 202410214630 A CN202410214630 A CN 202410214630A CN 117987446 A CN117987446 A CN 117987446A
- Authority
- CN
- China
- Prior art keywords
- phenazine
- carboxylic acid
- construction method
- strain
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JGCSKOVQDXEQHI-UHFFFAOYSA-N phenazine-1-carboxylic acid Chemical compound C1=CC=C2N=C3C(C(=O)O)=CC=CC3=NC2=C1 JGCSKOVQDXEQHI-UHFFFAOYSA-N 0.000 title claims abstract description 107
- 241000894006 Bacteria Species 0.000 title claims abstract description 23
- 238000010276 construction Methods 0.000 title claims abstract description 16
- 230000035772 mutation Effects 0.000 title claims description 6
- 101150023061 acpP gene Proteins 0.000 claims abstract description 22
- 101100000756 Bacillus subtilis (strain 168) acpA gene Proteins 0.000 claims abstract description 20
- 101150051130 acpP1 gene Proteins 0.000 claims abstract description 20
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 17
- 101100408257 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) phzM gene Proteins 0.000 claims abstract description 15
- 101100408260 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) phzS gene Proteins 0.000 claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 claims abstract description 9
- 239000002773 nucleotide Substances 0.000 claims description 15
- 125000003729 nucleotide group Chemical group 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 4
- 101150105457 phzM gene Proteins 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 101150093047 phzS gene Proteins 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 abstract description 13
- 238000000855 fermentation Methods 0.000 abstract description 6
- 230000004151 fermentation Effects 0.000 abstract description 6
- 206010064571 Gene mutation Diseases 0.000 abstract description 5
- 108010025955 Pyocins Proteins 0.000 abstract description 4
- 238000010353 genetic engineering Methods 0.000 abstract description 4
- 108020004414 DNA Proteins 0.000 description 16
- 239000012634 fragment Substances 0.000 description 16
- 239000002609 medium Substances 0.000 description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 230000003321 amplification Effects 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 241001240958 Pseudomonas aeruginosa PAO1 Species 0.000 description 5
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012257 pre-denaturation Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000003209 gene knockout Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 150000002988 phenazines Chemical class 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000000825 ultraviolet detection Methods 0.000 description 2
- WTFXTQVDAKGDEY-UHFFFAOYSA-N (-)-chorismic acid Natural products OC1C=CC(C(O)=O)=CC1OC(=C)C(O)=O WTFXTQVDAKGDEY-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 102000016397 Methyltransferase Human genes 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101150026476 PAO1 gene Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- WTFXTQVDAKGDEY-HTQZYQBOSA-N chorismic acid Chemical compound O[C@@H]1C=CC(C(O)=O)=C[C@H]1OC(=C)C(O)=O WTFXTQVDAKGDEY-HTQZYQBOSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
- A01N63/27—Pseudomonas
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1007—Methyltransferases (general) (2.1.1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
- C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/38—Pseudomonas
- C12R2001/385—Pseudomonas aeruginosa
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Biophysics (AREA)
- Environmental Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Mycology (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a phenazine-1-carboxylic acid producing gene mutation engineering bacterium, a construction method and application thereof, and belongs to the technical field of genetic engineering. The invention takes a pseudomonas aeruginosa strain CICC20240 with higher yield of pyocin as a starting strain, replaces Pa acpP with Ec acpP in the starting strain CICC20240, and simultaneously knocks out genes PA0051, PA5332, PA4209 and PA4217 to construct a genetic engineering strain with high PCA for production fermentation.
Description
Technical Field
The invention relates to the technical field of bioengineering, in particular to a phenazine-1-carboxylic acid gene mutation engineering bacterium, a construction method and application thereof.
Background
Phenazine-1-carboxylic acid (PCA) is a secondary metabolite secreted by Pseudomonas aeruginosa (Pseudomonas aeruginosa) and has a significant ability to inhibit a variety of plant pathogens. PCA is light yellow needle-shaped crystal at normal temperature, is slightly soluble in diethyl ether, benzene, chloroform and the like, and is difficult to dissolve in water. PCA has a melting point of 241-242 ℃ due to its special chemical structure, and is stable to heat and humidity. Scientists start with a PCA structural framework, carry out a large amount of chemical structural modification on the PCA structural framework, and design and synthesize a plurality of PCA derivatives with high biological activity. In 2011, PCA was registered as a novel biosynthetic fungicide, named "shenzinomycin". Experiments prove that the traditional Chinese medicine composition has good treatment effects on fusarium wilt, scab and sheath blight of melons, fruits, vegetables, cotton, wheat, rice and the like.
In pseudomonas aeruginosa, the biosynthetic pathway for PCA consists of phz (phzABCDEFG) gene clusters, which synthesizes a series of phenazine compounds including PCA with chorismate as a precursor. The chemical synthesis of phenazine pesticides is technically feasible, but has low yield and serious environmental pollution. Therefore, how to utilize microbial fermentation to biosynthesize phenazine compounds is an environment-friendly technology replacing chemical synthesis methods and is receiving extensive attention from researchers.
Disclosure of Invention
The invention aims to provide a phenazine-1-carboxylic acid producing gene mutation engineering bacterium, a construction method and application thereof, so as to solve the problems in the prior art.
In order to achieve the above object, the present invention provides the following solutions:
The invention provides a construction method of a phenazine-1-carboxylic acid producing genetic mutation engineering bacterium, which takes a wild strain CICC20240 as an original strain, knocks out phzM genes, crc genes, phzS genes and phzH genes, replaces the genes with Pa acpP genes, and finally obtains a strain CICC-M5 (delta Pa acpP:: ec acpP delta crcdelta phzH delta phzS delta phzM), namely the phenazine-1-carboxylic acid producing genetic mutation engineering bacterium.
Preferably, the nucleotide sequence of the phzM gene is shown as SEQ ID NO. 4.
Preferably, the nucleotide sequence of the crc gene is shown in SEQ ID NO. 2.
Preferably, the nucleotide sequence of phzS gene is shown in SEQ ID NO. 5.
Preferably, the nucleotide sequence of phzH gene is shown as SEQ ID NO. 3.
Preferably, the nucleotide sequence of the Pa acpP gene is shown as SEQ ID NO. 1.
The invention also provides the phenazine-1-carboxylic acid gene mutation engineering bacteria constructed by the construction method.
The invention also provides application of the phenazine-1-carboxylic acid producing genetically modified engineering bacteria in the production of phenazine-1-carboxylic acid.
The invention also provides a method for producing the phenazine-1-carboxylic acid, which utilizes the phenazine-1-carboxylic acid producing gene mutation engineering bacteria to produce the phenazine-1-carboxylic acid.
The invention also provides application of the phenazine-1-carboxylic acid producing genetically modified engineering bacteria in preparing plant disease-resistant preparations.
Based on the technical scheme, the invention has the following technical effects:
The invention takes a pseudomonas aeruginosa strain CICC20240 with higher yield of pyocin as a starting strain, replaces Pa acpP with Ec acpP, and simultaneously knocks out genes PA0051, PA5332, PA4209 and PA4217 to construct a genetic engineering strain with high PCA for production fermentation.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings that are needed in the embodiments will be briefly described below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and other drawings may be obtained according to these drawings without inventive effort for a person skilled in the art.
FIG. 1 is a block diagram of a phenazine-1-carboxylic acid (PCA);
FIG. 2 is a schematic diagram of the principle of homologous recombination knockout;
FIG. 3 is a PCR verification of the invention for CICC-M5 (ΔPa acpP:: ec acpP ΔcrcΔ phzH Δ phzS ΔphzM) mutants; wherein, lane 1 is a DNA fragment amplified by using a wild strain as a template and EcacpP P HindIII primer and EcacpP P BamHI primer, and lane 2 is a DNA fragment amplified by using a mutant strain as a template and the same primer; b. lane 1 is a DNA fragment amplified using a wild-type strain as a template, a phzM P1 HindIII primer and a phzM P4 BamHI primer, lane 2 is a DNA fragment amplified using a mutant strain as a template, a same primer is used, c.1 is a DNA fragment amplified using a wild-type strain as a template, a phzS P HindIII primer and a phzS P BamHI primer, lane 2 is a DNA fragment amplified using a mutant strain as a template, a same primer is used, d.1 is a DNA fragment amplified using a wild-type strain as a template, a phzH P HindIII primer and a phzH P BamHI primer, lane.1 is a DNA fragment amplified using a wild-type strain as a template, a crc P1 HindIII primer and a crP 4I primer, and Lane.2 is a DNA fragment amplified using a same primer; m represents DNA MARKER;
FIG. 4 is a chromatogram of HPLC analysis of a PCA standard;
FIG. 5 shows the measurement results of growth curve and PCA production curve of the Pseudomonas aeruginosa wild type CICC20240 and mutant CICC-M5 strain in PPM culture medium by shake flask fermentation; wherein A is the growth curve of each strain in LB culture medium, B is the PCA production curve of each strain in PPM culture medium;
FIG. 6 is a PCA production curve of Pseudomonas aeruginosa mutant CICC-M5 in PPM medium using a 10L fermenter.
Detailed Description
Various exemplary embodiments of the invention will now be described in detail, which should not be considered as limiting the invention, but rather as more detailed descriptions of certain aspects, features and embodiments of the invention.
It is to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. In addition, for numerical ranges in this disclosure, it is understood that each intermediate value between the upper and lower limits of the ranges is also specifically disclosed. Every smaller range between any stated value or stated range, and any other stated value or intermediate value within the stated range, is also encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although only preferred methods and materials are described herein, any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention. All documents mentioned in this specification are incorporated by reference for the purpose of disclosing and describing the methods and/or materials associated with the documents. In case of conflict with any incorporated document, the present specification will control.
It will be apparent to those skilled in the art that various modifications and variations can be made in the specific embodiments of the application described herein without departing from the scope or spirit of the application. Other embodiments will be apparent to those skilled in the art from consideration of the specification of the present application. The specification and examples of the present application are exemplary only.
As used herein, the terms "comprising," "including," "having," "containing," and the like are intended to be inclusive and mean an inclusion, but not limited to.
The technical scheme of the invention is conventional in the field, and the reagents or raw materials are purchased from commercial sources or are disclosed.
The embodiment of the invention aims to provide a pseudomonas aeruginosa mutant strain with high PCA yield, which is used for constructing and breeding genetic engineering bacteria of phenazine secondary metabolites. The genes involved in the invention are as follows:
The DNA sequence shown in SEQ ID No.1 is a sequence in the genome of Pseudomonas aeruginosa CICC20240, which is basically identical to the corresponding Gene Pa acpP in PAO1 (PA 2966, NCBI Gene ID: 879895) and consists of 237 nucleotides.
SEQ ID NO.1:ATGAGCACCATCGAAGAACGCGTTAAGAAGATCGTCGCTGA ACAACTCGGCGTGAAGGAAGAAGATGTCACCAACAGCGCTTCCTTCGTCCAAGACCTGGGCGCCGACTCCCTTGACACCGTCGAGCTGGTGATGGCTCTGGAAGAGGAATTCGAGACCGAAATCCCTGACGAGAAAGCTGAAAAGATCACCACCGTTCAGGAAGCCATCGACTACATCGTTGCTCACCAGCAATAA.
The DNA sequence shown in SEQ ID No.2 is a regulatory factor crc sequence (PA 5332, NCBI Gene ID: 878037) of a carbon source catabolism inhibition system in the P.aeruginosa PAO1 genome, and consists of 780 nucleotides.
SEQ ID NO.2:ATGCGGATCATCAGTGTGAACGTGAATGGTATTCAGGCTGCG GCCGAGCGCGGTTTGCTCAGTTGGCTGCAAGCACAGAATGCCGACGTGATCTGCTTGCAGGACACCCGAGCCTCCGCCTTCGATCTGGATGACCCGTCCTTCCAACTGGACGGCTACTTCCTTTATGCCTGCGATGCCGAGCTACCCGAACAGGGCGGTGTCGCACTCTACAGCCGTTTGCAGCCCAAAGCTGTGATCAGCGGCTTAGGTTTCGAAACGGCCGATCGTTACGGGCGCTACCTGCAAGCCGACTTCGACAAGGTGAGTATCGCCACCCTGCTGCTGCCTTCCGGGCAGAGCGGAGACGAGAGCTTGAACCAGAAATTCAAGTTCATGGACGACTTCACCCATTACTTGAGCAAGCAGCGTCGCAAGCGCCGCGAATACATCTACTGCGGCTCGCTGTACGTCGCCCATCAGAAGATGGATGTGAAGAACTGGCGCGAATGTCAGCAGATGCCGGGCTTCCTCGCGCCCGAACGGGCCTGGCTGGACGAAGTGTTCGGCAACCTCGGCTATGCCGACGCCCTGCGCGAAGTCAGCCGCGAAGGCGACCAGTTCAGCTGGTGGCCGGACAGCGAACAGGCCGAGATGCTCAACCTCGGCTGGCGCTTCGACTACCAGGTGCTGACCCCCGGCCTACGCCGCTTCGTGCGCAACGCCAAGCTGCCGCGCCAGCCGCGCTTCTCCCAGCATGCGCCGCTGATCGTCGACTACGACTGGCAGTTGAGCATCTGA.
The DNA sequence shown in SEQ ID NO.3 is the glutamine hydrolase phzH sequence in the P.aeruginosa PAO1 genome (PA 0051, NCBI Gene ID: 878637), consisting of 1833 nucleotides.
SEQ ID NO.3:ATGTGCGGTCTCGCGGGTTGGGTGGATTACACGCGCAAGCTC GACGACGAATTTCCGGCGATCTTCGCCATGACCGATACGCTCGCCTTGCGCGGGCCGGATGCCGAGGGCATCTGGAAGCACCGCAACGCCCTGCTGGGTCACCGGCGGCTGGCGGTCATCGACCTCAGCGGCGGCGTGCAGCCGATGTCCTATCGCTTTCCCACCGGCCAGGAGGTCACCCTCGTCTACACCGGCGAGGTGTACAACCACGATGCCC
TGCGCGAGCGGTTGCGCCGGGCCGGACATGAGTTCCGCACCCGCAGCGATACCG
AGGTGGTCCTGCACGCCTATCTGCAATGGGGCGAGCGTTGTTGCGAGTACCTGA
CCGGGATGTTCGCCTTCGCCGTCTTCGATGGCCGCGACGGCCACCTGCTGCTGGT
GCGCGACCGCCTGGGCATCAAGCCGCTGTATTACGCGCGGCACCGCGAGGGACT
GCTGTTCGGCTCGGAGATCAAGTCCATCCTGGCGCATCCGGAATTCGCCGCCAG
GCTCGACGCGGTCGGCCTGGTCGACCTCCTGACGCTGTCCCGGGGCACTTCGCA
GACGCCGTTCCGCGAGGTCCAGGAACTGCTGCCCGGCCACCTGCTGTCCTGGCG
TCCCAATTCCCAGGCGAAGTTGCGCCGCTACTGGGAGGTGCGCCGCCAGGAGCA
TGCCGACGACCTGCAGAGCACCGTGCAGCGCACCCGCGAACTGGTCACCCGCGC
CCTGGGGGCGCAATTGCACGCCGACGTTCCGGTGTGTTCGCTGCTATCGGGTGG
GCTCGATTCGACCGCCCTGACCGGCATCGCCCAGCGCATCGCGAAGGCGGAGCA
CGGCGGCGACATCAATTCGTTCTCGGTGGACTTCGTCGGCCAGGCCGAGCAGTT
CCGCAGCGACGACCTGCGTCCCGACCAGGACCAGCCGTTCGCCCTGCTGGCCGC
GCAGTACATCGGCAGCCGTCATCGCACCGTGCTCATCGACAATGCCGAACTGGT
CTGCGAACGAGCGCGCGAAGAGGTATTCCGGGCCAAGGACGTACCTTTCACCTT
CGGCGACATGGATACCTCGCTGCACCTGATGTTCGGCGAGATCCGCCGGCATTC
CACGGTGGCCATCTCCGGTGAAGGCGCCGACGAGCTGTTCGGTGGCTACGGCTG
GTTCCGCGATCCGCAGGCGGTGGCTGCGGCGCGCTTCCCCTGGGCCTCCAGGGT
GCGCCTGCCGGCCGGCTTCATCGACGCCGGTTTCAACCGCCGCTGCGATCTCCTC
CAGTACCAGCAGGCCAGCTACGACGATGGGCTGCGCCAGGTCGAACACCTGGCC
GGCGACAGCCCGGAGGAGCGGCGGATGCGCGAGTTCAGCCACCTGCATCTGAA
GCGCTGGATGGTGCTGCTGCTCGAACGCAAGGATCGCCTGAGCATGTGCAACGG
CCTGGAGGTGCGGGTGCCCTACACCGACCATGAGCTGGTGGAGTACGTCTACAA
CGTGCCCTGGTCGATCAAGAGCCGGGACGGCGAGGAGAAGTGGCTGCTCAAGC
GGGCCTGCGCCGACTATGTCCCGGAAGCCGTGCTCAAGCGCCGCAAGAGCCCTT
ATCCGACTTCTGCCAACCTCGGCTACGAGCGTTTCCTGCGCGGGAGCGTGCGGC
GCCTGCTGGAGGACGCGGTGAACCCGGTGTTCGGCATCGTTTCGCGAGAGTTCC
TGGCCGCCGAACTGGAGCATCCGGAGGGGTACTTCAACACCCAGGTGAGCCGCC
ACAACCTGGAGACCGCACTGGCGCTGGAAGGCTGGCTCAGGTTGTACGGGCTCTCCGCCTGA。
The DNA sequence shown in SEQ ID No.4 is the phenazine specific methyltransferase phzM sequence in the P.aeruginosa PAO1 genome (PA 4209, NCBI Gene ID: 880514), consisting of 1005 nucleotides.
SEQ ID NO.4:ATGAATAATTCGAATCTTGCTGCTGCGCGTAATTTGATACAA GTTGTTACCGGGGAATGGAAGTCCCGTTGCGTCTACGTCGCTACGCGCCTCGGGCTGGCCGATCTGATCGAGAGCGGGATCGACAGCGACGAGACGCTGGCCGCCGCGGTCGGTTCCGATGCCGAGCGCATCCATCGACTGATGCGCCTGCTGGTGGCCTTCGAGATCTTCCAGGGCGATACCCGCGACGGCTACGCCAATACCCCCACCAGCCACCTGCTGAGGGATGTCGAGGGCTCCTTCCGCGACATGGTGCTGTTCTACGGCGAGGAGTTCCACGCCGCCTGGACGCCCGCCTGCGAGGCGCTGCTCAGCGGTACCCCAGGCTTCGAGCTGGCGTTCGGCGAAGACTTCTACAGCTACCTGAAGCGCTGCCCGGATGCCGGCCGGCGCTTCCTGCTGGCGATGAAGGCGAGCAACCTGGCATTCCACGAGATCCCCAGGCTCCTGGATTTCCGCGGGCGTAGCTTCGTCGACGTCGGTGGCGGTTCCGGCGAATTGACCAAGGCCATCCTGCAGGCCGAGCCCAGCGCCCGGGGCGTGATGCTCGACCGCGAGGGTTCCCTCGGCGTGGCCCGCGACAACCTTTCCAGCCTGTTGGCAGGGGAGCGCGTCAGCCTGGTGGGCGGCGACATGCTGCAAGAGGTGCCGTCCAACGGCGATATCTACCTGCTGTCGCGGATCATCGGCGATCTGGACGAAGCCGCCAGCCTGCGGTTGCTCGGCAATTGCCGCGAGGCGATGGCCGGCGACGGCCGGGTGGTGGTGATCGGCGGACCATCTCGGCCAGCGAGCCGTCGCCGATGTCGGTGCTCTGGGACGTGCACCTGTTCATGGCCTGCGCTGGCCGTCACCGCACCACCGAGGAGGTGGTCGACCTGCTCGGGCGCGGCGGCTTCGCGGTGGAGCGGATCGTCGACCTGCCGATGGAAACCCGCATGATCGTCGCTGCCAGGGCCTGA.
The DNA sequence shown in SEQ ID No.5 is a sequence in the genome of Pseudomonas aeruginosa PAO1, and the coding Gene phzS (PA 4217, NCBI Gene ID: 881836) consists of 1209 nucleotides.
SEQ ID NO.5:ATGAGCGAACCCATCGATATCCTCATCGCCGGCGCCGGCAT CGGCGGCCTCAGTTGCGCCCTGGCCCTGCACCAGGCCGGCATCGGCAAGGTCACGCTGCTGGAAAGCAGCAGCGAGATACGCCCCCTTGGCGTCGGCATCAATATCCAGCCGGCGGCGGTCGAGGCCCTTGCCGAACTGGGCCTCGGCCCGGCGCTGGCGGCCACCGCCATCCCCACCCACGAGCTGCGCTACATCGACCAGAGCGGCGCCACGGTATGGTCCGAGCCGCGCGGGGTGGAAGCCGGCAACGCCTATCCGCAGTACTCGATCCATCGCGGCGAACTGCAGATGATCCTGCTCGCCGCGGTGCGCGAGCGCCTCGGCCAACAGGCGGTACGCACCGGTCTCGGCGTGGAGCGTATCGAGGAGCGCGACGGCCGCGTGCTGATCGGCGCCCGCGACGGACACGGCAAGCCCCAGGCGCTCGGTGCCGATGTGCTGGTCGGCGCCGACGGTATCCATTCGGCGGTCCGCGCGCACCTGCATCCCGACCAGAGGCCGCTGTCCCACGGTGGGATCACCATGTGGCGCGGCGTCACCGAGTTCGACCGCTTCCTCGACGGCAAGACCATGATCGTCGCCAACGACGAGCACTGGTCGCGCCTGGTCGCCTATCCGATCTCGGCGCGTCACGCGGCCGAAGGCAAGTCGCTGGTGAACTGGGTGTGCATGGTGCCGAGCGCCGCCGTCGGCCAGCTCGACAACGAGGCCGACTGGAACCGCGACGGGCGCCTGGAGGACGTGCTGCCGTTCTTCGCCGACTGGGACCTGGGCTGGTTCGACATCCGCGACCTGCTGACCCGCAACCAGTTGATCCTGCAGTACCCGATGGTAGACCGCGATCCGCTGCCGCACTGGGGCCGGGGACGCATCACCCTGCTCGGCGACGCCGCCCACCTGATGTATCCGATGGGCGCCAACGGCGCTTCGCAAGCAATCCTCGACGGCATCGAGCTGGCCGCCGCGCTGGCGCGCAACGCCGACGTGGCCGCAGCCCTGCGCGAATACGAAGAAGCGCGGCGGCCGACCGCCAACAAGATCATCCTGGCCAACCGAGAACGGGAAAAAGAGGAATGGGCCGCGGCTTCGCGACCGAAGACCGAGAAGAGCGCGGCGCTGGAAGCGATCACCGGCAGCTACCGCAACCAGGTGGAACGGCCACGCTAG.
In the embodiment of the invention, a wild strain CICC20240 is purchased from China center for type culture Collection of industrial microorganisms, escherichia coli S17-1 and suicide plasmid pK18mobsacB are used as the units for preservation, and knocked-out plasmids pK18DM, pK18DacpP, pK18DS, pK18DH and pK18Dcrc are used as the structures of the invention;
Reagents such as restriction enzymes, ligases, etc. were purchased from the division of biological engineering (Shanghai);
PCR primers were synthesized by Guangzhou division, a division of biological engineering (Shanghai) Co.
EXAMPLE 1 construction of CICC-M5 (ΔPa acpP::: ec acpP ΔcrcΔ phzH Δ phzS ΔphzM) Gene knockout mutant
Primers were designed based on the target gene and the upstream and downstream sequences (see Table 1, the underlined part is the cleavage site):
TABLE 1 primer sequences
Construction of CICC ΔphzM mutant:
To obtain the CICC ΔphzM mutant, a phzM knockout vector is first constructed based on the PA4209 gene and upstream and downstream sequences. The total DNA of pseudomonas aeruginosa CICC20240 is used as a template, and primers P1, P2, P3 and P4 are respectively used for amplification to obtain fragments of about 600bp on the upstream and downstream of the phzM gene.
25. Mu.L amplification system: 1. Mu.L of total DNA, 1. Mu.L of each primer, and 22. Mu.L of PCR Mix.
Amplification conditions: pre-denaturation at 98℃for 12min, denaturation at 98℃for 10s, annealing at 60℃for 10s, and extension at 72℃for 15s. Number of program cycles: 35 cycles.
In the invention, P2 and P3 are reversely complemented in advance during primer design, and the upstream and downstream fragment genes of the phzM gene can be spliced by using P1 and P4 as primers by utilizing an overlap extension PCR method.
25. Mu.L amplification system: 1. Mu.L of each of the P1 and P2 fragments and the P3 and P4 fragments, 1. Mu.L of each of the P1 and P4 primers, and 21. Mu.L of PCR Mix.
Amplification conditions: pre-denaturation at 98℃for 12min, denaturation at 98℃for 10s, annealing at 60℃for 10s, and extension at 72℃for 30s. Number of program cycles: 35 cycles.
The P1, P4 knockout cassette fragments after overlap extension were digested with plasmid pK18mobsacB using restriction endonucleases HindIII and BamHI (restriction conditions: 25. Mu.L for DNA fragment or plasmid, 10 Xrestriction buffer 5. Mu.L for BamHI 2. Mu.L, hindIII 2. Mu.L for double distilled water to 50. Mu.L for reaction at 37℃for 4 hours), and the two were ligated by T4 DNA LIGASE (ligation conditions: 2. Mu.L for linearized vector DNA, 15. Mu.L for insert DNA, 10 Xrestriction buffer 2. Mu.L for T4 DNA ligase 0.2. Mu.L, double distilled water to 20. Mu.L for metal bath incubation at 22 ℃) and colony PCR screening (10. Mu.L for amplification system: 1. Mu.L for positive recombinant bacteria, 0.5. Mu.L for primers P1, P4 each, dNTP 0.5. Mu.L for each, and Mix 8. Mu.L for PCR: 98℃for pre-denaturation 12min,98℃denaturation 10s,60℃annealing 10s for 30 cycles at 72 ℃).
Screening to obtain positive recombinant and sequencing to obtain knocked out plasmid pK18DM.
The plasmid pK18DM after sequencing is transformed into the escherichia coli S17-1 strain by heat shock, the plasmid is transferred into pseudomonas aeruginosa cells by bacterial conjugation, and homologous recombination occurs (the recombination principle schematic diagram is shown in figure 2). The primary recombinant conjugation product was plated on LB solid medium containing Gm (100. Mu.g/mL), and the single colony obtained was a primary recombinant. After identification and streaking purification by colony PCR, one recombinant was selected and cultured overnight in a non-resistant LB liquid medium at 220rpm, the supernatant was removed after centrifugation of the bacterial liquid, and transferred to a non-resistant ME liquid medium containing 20% sucrose for 2 hours. The cultures were then spread on a non-resistant ME solid medium containing 20% sucrose for 2 days until single colonies developed. The recombinants were identified by PCR using primers P1, P4 to determine whether the obtained strain was the desired strain (results are shown in FIG. 3).
By the same method, a single mutant strain CICC delta phzM starting strain is used for knocking out the crc gene to obtain a double mutant strain delta phzM delta crc, and then the double mutant strain is used as the starting strain to step-wise knock out phzS and phzH and replace Pa acpP genes, so that the strain CICC-M5 (delta Pa acpP: ec acpP delta crc delta phzH delta phzS delta phzM) is finally obtained.
EXAMPLE 2 detection of the content of CICC-M5 phenazine-1-carboxylic acid in the mutant
The extraction and detection method of phenazine-1-carboxylic acid comprises the following steps:
1. Target bacteria were inoculated into 15mL centrifuge tubes containing 5mL of non-resistant LB liquid medium and shake-cultured overnight at 37 ℃.
2. 5ML of the seed solution was transferred to a 250mL triangular flask containing 100mL of PPM medium, and the flask was placed in a shaking table at 37℃for shake culture at a rotation speed of 220rpm.
3. 180 Mu L of thallus is taken every 12h, 20 mu L of 6M hydrochloric acid is added, and the mixture is stirred and mixed for 10 seconds.
4. 540 Μl of chloroform was added and shaken for two minutes. The organic phase was separated from the aqueous phase by centrifugation at 12000rpm for 10min, and the chloroform phase was taken in 300. Mu.L to a clean 1.5mL centrifuge tube, concentrated by centrifugation and evaporated to dryness.
5. The evaporated sample was resuspended in 900. Mu.L of chloroform and after sufficient dissolution, the sample was centrifuged at 12000rpm for 10min to remove impurities.
6. 200. Mu.L of the upper aqueous phase was taken and subjected to HPLC detection.
PCA was quantitatively detected by HPLC.
Instrument model: shimadzu LC-20A;
analytical column: aglient XDB C18.5 μm, 4.6X105 mm;
Mobile phase: 40% A:10mM ammonium acetate 60% B: acetonitrile;
Sample injection amount: 20. Mu.L;
Column temperature: 28 ℃;
Ultraviolet detection wavelength: 254nm;
Flow rate: 0.7ml/min.
PCA standard samples with different concentrations are configured for detection, and a standard curve is drawn according to the linear relation between peak area and concentration: PCA (mg/L) =0.000002 x-1.7768 (R 2 =0.999), the chromatogram is shown in FIG. 4, the ultraviolet detection wavelength is 254nm, and the peak time is 3.9min.
Example 3
The PCA yields of the original strain CICC20240 and the mutant CICC-M5 mutant were determined by shake flask fermentation in PPM medium. As shown in FIG. 5a, the growth curve of the original strain CICC20240 and CICC-M5 in LB medium has no obvious difference, the maximum OD 600nm is 1.84, the strain enters the stabilization period after 36h, and the gene knockout has little effect on the growth of bacteria. The measurement result of the PCA yield is shown in FIG. 5b, and the PCA concentration of the penta-mutant strain CICC-M5 reaches a maximum value 81.42mg/L after 60 hours of culture. In LB medium, the PCA yield of CICC-M5 is improved by about 19.86 times compared with that of the original strain CICC 20240. Mutant CICC-M5 was cultured in a 10L fermenter using PPM medium and its PCA yield was determined. As shown in FIG. 6, the mutant CICC-M5, which was fermented in PPM medium, reached the maximum concentration of PCA at 48 hours, which was 1052.7mg/L, and at this time, a rapid decrease in dissolved oxygen was observed, presumably due to exhaustion of nutrients in the medium, and the bacteria died in large amounts, and continued metabolism was not possible to produce PCA.
In summary, the invention takes the pseudomonas aeruginosa strain CICC20240 with higher yield of the pyocin as an original strain, the CICC20240 is identified as pseudomonas aeruginosa, and the experiment refers to the pseudomonas aeruginosa PAO1 genome sequence and a sequencing fragment obtained by PCR amplification of the total DNA of the bacteria CICC20240 to design primers. The Pa acpP is replaced by the Ec acpP in the original strain CICC20240, meanwhile, the synthesis process of the pyocin is blocked, and the genes PA0051, PA5332, PA4209 and PA4217 are knocked out, so that the genetically engineered strain with high PCA is constructed for producing fermentation.
It is to be understood that the above examples of the present invention are provided for clarity of illustration only and are not limiting of the embodiments of the present invention. Other variations or modifications of the above description will be apparent to persons of ordinary skill in the art. It is not necessary here nor is it exhaustive of all embodiments. Any modification, equivalent replacement, improvement, etc. which come within the spirit and principles of the invention are desired to be protected by the following claims.
Claims (10)
1. A construction method of a phenazine-1-carboxylic acid producing genetic mutation engineering bacterium is characterized in that a wild strain CICC20240 is taken as an original strain, phzM genes, crc genes, phzS genes and phzH genes are knocked out and replaced by Pa acpP genes, and a strain CICC-M5 (delta Pa acpP:: ec acpP delta crcdelta phzH delta phzS delta phzM) is finally obtained, namely the phenazine-1-carboxylic acid producing genetic mutation engineering bacterium.
2. The construction method according to claim 1, wherein the nucleotide sequence of the phzM gene is shown in SEQ ID No. 4.
3. The construction method according to claim 1, wherein the nucleotide sequence of the crc gene is shown in SEQ ID NO. 2.
4. The construction method according to claim 1, wherein the nucleotide sequence of phzS gene is shown in SEQ ID NO. 5.
5. The construction method according to claim 1, wherein the nucleotide sequence of phzH gene is shown in SEQ ID NO. 3.
6. The construction method according to claim 1, wherein the nucleotide sequence of the Pa acpP gene is shown as SEQ ID No. 1.
7. The phenazine-1-carboxylic acid producing genetically engineered bacterium constructed by the construction method according to any one of claims 1 to 6.
8. The use of the genetically engineered bacterium for producing phenazine-1-carboxylic acid according to claim 7 in the production of phenazine-1-carboxylic acid.
9. A method for producing phenazine-1-carboxylic acid, wherein the phenazine-1-carboxylic acid is produced by using the phenazine-1-carboxylic acid producing genetically engineered bacterium of claim 7.
10. The use of a phenazine-1-carboxylic acid producing genetically engineered bacterium as defined in claim 7 in the preparation of a plant disease resistant formulation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410214630.2A CN117987446A (en) | 2024-02-27 | 2024-02-27 | Genetic mutation engineering bacteria for producing phenazine-1-carboxylic acid, construction method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410214630.2A CN117987446A (en) | 2024-02-27 | 2024-02-27 | Genetic mutation engineering bacteria for producing phenazine-1-carboxylic acid, construction method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117987446A true CN117987446A (en) | 2024-05-07 |
Family
ID=90888547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410214630.2A Pending CN117987446A (en) | 2024-02-27 | 2024-02-27 | Genetic mutation engineering bacteria for producing phenazine-1-carboxylic acid, construction method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117987446A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105087455A (en) * | 2015-03-27 | 2015-11-25 | 上海交通大学 | Genetic engineering strain for producing phenazine-1-carboxylic acid and application of genetic engineering strain |
CN109777760A (en) * | 2017-11-14 | 2019-05-21 | 上海交通大学 | The engineering strain and cultural method of less toxic high yield fungicide azophenlyene -1- amide and application |
CN111849851A (en) * | 2020-08-12 | 2020-10-30 | 华南农业大学 | High-yield pyocin engineering bacterium and construction method and application thereof |
-
2024
- 2024-02-27 CN CN202410214630.2A patent/CN117987446A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105087455A (en) * | 2015-03-27 | 2015-11-25 | 上海交通大学 | Genetic engineering strain for producing phenazine-1-carboxylic acid and application of genetic engineering strain |
CN109777760A (en) * | 2017-11-14 | 2019-05-21 | 上海交通大学 | The engineering strain and cultural method of less toxic high yield fungicide azophenlyene -1- amide and application |
CN111849851A (en) * | 2020-08-12 | 2020-10-30 | 华南农业大学 | High-yield pyocin engineering bacterium and construction method and application thereof |
Non-Patent Citations (2)
Title |
---|
JIN-CHENG MA ET AL.,: ""Only acyl carrier protein 1 (AcpP1) functions in Pseudomonas aeruginosa fatty acid synthesis"", 《FRONTIERS IN MICROBIOLOGY》, vol. 8, 10 November 2017 (2017-11-10), pages 4 * |
邱薇等: ""假单胞菌属双组分信号转导系统调控吩嗪生物合成研究进展"", 《微生物学通报》, vol. 49, no. 1, 20 January 2022 (2022-01-20), pages 352 - 362 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101814888B1 (en) | 5-aminolevulinic acid high-yield bacterial strain, preparation method and uses thereof | |
Jin et al. | Engineering the central biosynthetic and secondary metabolic pathways of Pseudomonas aeruginosa strain PA1201 to improve phenazine-1-carboxylic acid production | |
CN102994439A (en) | Escherichia coli recombinant strain producing shikimic acid, and construction method and application thereof | |
CN110591989A (en) | High-yield L-tryptophan engineering strain and application thereof | |
CN106754607A (en) | A kind of recombinant bacterial strain and its construction method for producing tyrosol | |
CN110382684A (en) | Generate the plum surprise yeast kind of xylitol | |
CN104630100A (en) | Reconstructed Klebsiella pneumoniae and application of reconstructed Klebsiella pneumoniae in production of R-acetoin | |
CN108998401B (en) | Method for producing 3-aminoisobutyric acid | |
Xiang et al. | Overexpressing codon-adapted fusion proteins of 4-coumaroyl-CoA ligase (4CL) and stilbene synthase (STS) for resveratrol production in Chlamydomonas reinhardtii | |
CN111154665B (en) | Recombinant yarrowia lipolytica and construction method and application thereof | |
CN104745557A (en) | Halohydrin dehalogenase mutant from parvibaculum lavamentivorans and application of halohydrin dehalogenase mutant | |
Rønnow et al. | Derepression of galactose metabolism in melibiase producing bakers’ and distillers’ yeast | |
KR102473375B1 (en) | Recombinant microorganisms, their preparation methods and their use in the production of coenzyme Q10 | |
Chen et al. | Ribosome-binding sequences (RBS) engineering of key genes in Escherichia coli for high production of fatty alcohols | |
CN117987446A (en) | Genetic mutation engineering bacteria for producing phenazine-1-carboxylic acid, construction method and application thereof | |
CN113481233B (en) | Method for constructing ectoin producing strain | |
CN110218691A (en) | One plant of genetic engineering bacterium for synthesizing altheine and its construction method and application | |
CN115948402A (en) | Recombinant Shewanella capable of producing 5-aminolevulinic acid and application thereof | |
CN115838713A (en) | Protease and application thereof in L-carnosine synthesis | |
Xiang-Lei et al. | Enhanced production of shikimic acid using a multi-gene co-expression system in Escherichia coli | |
CN106222191B (en) | Knock out method of the central carbon metabolism gene to improve Ge Erdeng element fermentation level | |
CN116064596B (en) | Saccharomyces cerevisiae multidrug resistance transcription factor gene YRR mutant YRR1T185AAnd applications thereof | |
Lee et al. | Reverse engineering targets for recombinant protein production in Corynebacterium glutamicum inspired by a fast-growing evolved descendant | |
CN114806992B (en) | RSH over-expression genetic engineering amylase streptomyces chromogenes and method for improving fermentation yield of toyocamycin | |
CN114438004B (en) | Saccharopolyspora erythraea engineering strain with doubled pII gene, and construction method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |